| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.08B | +3.7% |
| Cost of Revenue | $472.3M | +0.3% |
| R&D Expense | $145.1M | +5.4% |
| SG&A Expense | $93.8M | +4.4% |
| Operating Income | $279.8M | +7.0% |
| Pre-tax Income | $285.9M | +7.2% |
| Income Tax | $65.9M | +36.1% |
| Net Income | $219.9M | +0.7% |
| EPS (Basic) | $3.64 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $328.7M | +23.5% |
| Accounts Receivable | $214.7M | +4.5% |
| Current Assets | $583.3M | +15.9% |
| Total Assets | $839.4M | +10.8% |
| Current Liabilities | $455.9M | +13.9% |
| Stockholders' Equity | $314.8M | +5.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $389.5M | +32.0% |
| Capital Expenditures | $15.5M | +78.2% |
| Investing Cash Flow | -$15.5M | -78.2% |
| Financing Cash Flow | -$315.2M | -10.1% |
| Free Cash Flow | $374.0M | +30.6% |
| +2.2% |
| EPS (Diluted) | $3.60 | +2.6% |